SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-129813
Filing Date
2019-04-30
Accepted
2019-04-30 17:27:55
Documents
3
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A d656607ddefa14a.htm DEFA14A 19424
2 GRAPHIC g656607dsp004.jpg GRAPHIC 274042
3 GRAPHIC g656607dsp005.jpg GRAPHIC 160612
  Complete submission text file 0001193125-19-129813.txt   619493
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Unum Therapeutics Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38443 | Film No.: 19783416
SIC: 2834 Pharmaceutical Preparations